Literature DB >> 8637716

The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.

H H Nandurkar1, D J Hilton, P Nathan, T Willson, N Nicola, C G Begley.   

Abstract

We describe the molecular cloning of a cDNA for the alpha chain of the human IL-11 receptor (IL-11R alpha) and demonstrate the requirement of either the human or mouse gp130 molecule for signalling. cDNA clones encoding IL-11R alpha were isolated from a bone marrow cDNA library using a fragment from the murine IL-11R alpha as a probe. The human receptor was predicted to consist of 422 amino acids and was found to share 84% identity with the murine protein. In the extra-cellular region it exhibited a single hemopoietin domain with conserved cysteine residues and WSTWS motif. The transmembrane region was followed by a short cytoplasmic tail which did not contain a tyrosine kinase domain. Interaction of the human IL-11R alpha with murine gp130 was demonstrated: expression of the human IL-11R alpha in murine M1 cells which constitutively express murine gp130 (and murine LIF receptor), resulted in the generation of specific high-affinity binding sites for IL-11 (Kd = 250 pM). In addition, expression of the human IL-11R alpha in these cells permitted the induction of macrophage differentiation in response to IL-11. These results suggested that the human IL-11R alpha chain was able to form a functional receptor complex in association with murine gp130. The requirement of gp130 for signalling was confirmed by expression of the human IL-11R alpha in Ba/F3 cells. BaF3 cells that expressed the human IL-11R alpha alone showed binding of radiolabelled IL-11 but no proliferative response. Introduction of human gp130 into these cells resulted in high-affinity IL-11 binding sites and IL-11 dependent cellular proliferation. Thus these results demonstrated the absolute requirement of gp130 for signalling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8637716

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Functional expression of the interleukin-11 receptor alpha-chain in normal colonic epithelium and colon cancer.

Authors:  Nicole Deutscher; Frauke Bataille; Martin Hausmann; Stephan Kiessling; Gerhard Muller-Newen; Sandra N Leeb; Hans Herfarth; Peter C Heinrich; Jürgen Schölmerich; Gerhard Rogler
Journal:  Int J Colorectal Dis       Date:  2005-11-15       Impact factor: 2.571

2.  Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.

Authors:  H Dahmen; U Horsten; A Küster; Y Jacques; S Minvielle; I M Kerr; G Ciliberto; G Paonessa; P C Heinrich; G Müller-Newen
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

3.  The length of the interleukin-11 receptor stalk determines its capacity for classic signaling.

Authors:  Juliane Lokau; Christoph Garbers
Journal:  J Biol Chem       Date:  2018-03-09       Impact factor: 5.157

4.  The binding characteristics of a cyclic nonapeptide, c(CGRRAGGSC), in LNCaP human prostate cancer cells.

Authors:  Chen Gu; Lu Liu; Yujie He; Jianwei Jiang; Zexuan Yang; Qinghua Wu
Journal:  Oncol Lett       Date:  2012-06-21       Impact factor: 2.967

5.  Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor.

Authors:  Anuradha Pradhan; Que T Lambert; Gary W Reuther
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

6.  Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats.

Authors:  Rachel J Gibson; Dorothy M K Keefe; Fiona M Thompson; Julie M Clarke; Gary J Goland; Adrian G Cummins
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

7.  Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth.

Authors:  Pathum Thilakasiri; Jennifer Huynh; Ashleigh R Poh; Chin Wee Tan; Tracy L Nero; Kelly Tran; Adam C Parslow; Shoukat Afshar-Sterle; David Baloyan; Natalie J Hannan; Michael Buchert; Andrew Mark Scott; Michael Dw Griffin; Frederic Hollande; Michael W Parker; Tracy L Putoczki; Matthias Ernst; Ashwini L Chand
Journal:  EMBO Mol Med       Date:  2019-04       Impact factor: 12.137

8.  In Silico Identification and Clinical Validation of a Novel Long Non-Coding RNA/mRNA/miRNA Molecular Network for Potential Biomarkers for Discriminating SARS CoV-2 Infection Severity.

Authors:  Sara H A Agwa; Hesham Elghazaly; Mahmoud Shawky El Meteini; Sherif M Shawky; Marwa Ali; Aya M Abd Elsamee; Safa Matbouly Sayed; Nadine Sherif; Howida M Sharaf; Mohamed A Alhadidy; Marwa Matboli
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

9.  Qualitative modeling identifies IL-11 as a novel regulator in maintaining self-renewal in human pluripotent stem cells.

Authors:  Hedi Peterson; Raed Abu Dawud; Abhishek Garg; Ying Wang; Jaak Vilo; Ioannis Xenarios; James Adjaye
Journal:  Front Physiol       Date:  2013-10-28       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.